Free Cash Flow Build Up

CytRx Corporation (CYTR)

$ 3.24
0.4 (+14.08%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 0.300.100.100.200.100.250.330.440.590.791.051.401.87
EBITDA -27.47-49.42-62.96-51.72-32.24-8.22-7.84-6.60-138.35-184.46-245.95-327.93-437.25
EBIT -27.59-49.61-63.28-52.26-32.87-8.25-7.86-6.83-139.46-185.95-247.94-330.58-440.78
Tax Rate -0.00%-0.00%-0.00%-0.00%-0.00%-40.04%4.78%-0.01%-4.41%-4.41%-4.41%-4.41%-4.41%
EBIAT -27.60-49.61-63.28-52.26-32.87-11.55-7.49-6.83-145.62-194.15-258.87-345.16-460.22
Depreciation 0.120.180.320.540.630.030.020.231.121.491.992.653.53
Accounts Receivable --2-2.504.44-7.357.380.14-0.32-10.45-3.59-4.79-6.38-8.51
Inventories -------------
Accounts Payable -2.801.40-1.65-2.28-2.89-0.350.5116.676.028.0310.7114.28
Capital Expenditure -0.04-0.96-0.33-1.02-0.13-0.01-0.02-0.03-1.45-1.94-2.59-3.45-4.60
UFCF -27.52-49.58-64.39-49.96-42.01-7.04-7.70-6.43-139.73-192.17-256.23-341.64-455.52
WACC
PV UFCF -7.70-5.40-98.69-114.07-127.82-143.22-160.49
SUM PV UFCF -766.63